Evidence map›Paper›PMID 15380036›Full record

ReviewArthritis research & therapy2004

Regulating the immune system: the induction of regulatory T cells in the periphery.

Jane H Buckner, Steven F Ziegler

Open access · diamondAbstract readReview
In one paragraph

Review in Arthritis research & therapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Suppressor CD4Gut · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Effectiveness of Antihyperglycemic Effect ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury.Journal of the American Society of Nephrology : JASN · 2009
    Article
  18. Article
  19. CD4 regulatory T cells in human cancer pathogenesis.Cancer immunology, immunotherapy : CII · 2007
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jane H BucknerDiabetes Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Steven F Ziegler
Benaroya Research InstituteSeattle University · US

Funding

FOXP3: functional analysis of the gene mutated in miceR01AI048779 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2002 to 2006
$1.9M
IPEX and Scurfin/FoxP3: Dysregulation of T cellsR21AI054610 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2003 to 2004
$527k
NIAID NIH HHS AI48779NIAID NIH HHS AI54610NIAID NIH HHS R01 AI048779NIAID NIH HHS R21 AI054610
6 · The paper itself

Abstract

The immune system has evolved a variety of mechanisms to achieve and maintain tolerance both centrally and in the periphery. Central tolerance is achieved through negative selection of autoreactive T cells, while peripheral tolerance is achieved primarily via three mechanisms: activation-induced cell death, anergy, and the induction of regulatory T cells. Three forms of these regulatory T cells have been described: those that function via the production of the cytokine IL-10 (T regulatory 1 cells), transforming growth factor beta (Th3 cells), and a population of T cells that suppresses proliferation via a cell-contact-dependent mechanism (CD4+CD25+ TR cells). The present review focuses on the third form of peripheral tolerance - the induction of regulatory T cells. The review will address the induction of the three types of regulatory T cells, the mechanisms by which they suppress T-cell responses in the periphery, the role they play in immune homeostasis, and the potential these cells have as therapeutic agents in immune-mediated disease.

Indexed as

AnimalsHumansImmune SystemImmune ToleranceT-Lymphocytes

Identifiers

PMID15380036
PMCPMC546291
OpenAlexW2127654037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.